Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
How to buy Celldex Therapeutics (CLDX) stocks in Canada
Learn how to easily invest in Celldex Therapeutics stocks.
Celldex Therapeutics is a biotechnology business based in the US. Celldex Therapeutics stocks (CLDX.US) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $31.04 – a decrease of 8.62% over the previous week. Celldex Therapeutics employs 123 staff and has a trailing 12-month revenue of around $8.1 million.
How to buy shares in Celldex Therapeutics
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – CLDX – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
What's in this guide?
- Can I buy shares in Celldex Therapeutics?
- Has coronavirus impacted Celldex Therapeutics shares?
- Celldex Therapeutics shares summary
- Compare share dealing platforms
- Is Celldex Therapeutics stock a buy or sell?
- Celldex Therapeutics performance over time
- Celldex Therapeutics's financials
- How volatile are Celldex Therapeutics shares?
- Does Celldex Therapeutics pay a dividend?
- Have Celldex Therapeutics shares ever split?
- Other common questions
Celldex Therapeutics stock price (NASDAQ:CLDX)Use our graph to track the performance of CLDX stocks over time.
Celldex Therapeutics shares at a glance
|Latest market close||$29.16|
|52-week range||$15.37 - $57.20|
|50-day moving average||$39.43|
|200-day moving average||$39.25|
|Wall St. target price||$65.17|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-1.76|
Compare online stock trading platforms
Note: The dollar amounts in the table below are in Canadian dollars.
Is it a good time to buy Celldex Therapeutics stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Celldex Therapeutics price performance over time
|1 week (2022-01-13)||-3.19%|
|1 month (2021-12-20)||-25.46%|
|3 months (2021-10-17)||N/A|
|6 months (2021-07-21)||-32.66%|
|1 year (2021-01-21)||62.63%|
|2 years (2020-01-21)||1,151.50%|
|3 years (2019-01-18)||8,438.80%|
|5 years (2017-01-20)||755.13%|
Celldex Therapeutics financials
|Revenue TTM||$8.1 million|
|Gross profit TTM||$-35,116,000|
|Return on assets TTM||-10.27%|
|Return on equity TTM||-21.68%|
|Market capitalisation||$1.5 billion|
TTM: trailing 12 months
Celldex Therapeutics share dividends
We're not expecting Celldex Therapeutics to pay a dividend over the next 12 months.
Have Celldex Therapeutics's shares ever split?
Celldex Therapeutics's shares were split on a 1:15 basis on 10 February 2019. So if you had owned 15 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Celldex Therapeutics shares – just the quantity. However, indirectly, the new 1400% higher share price could have impacted the market appetite for Celldex Therapeutics shares which in turn could have impacted Celldex Therapeutics's share price.
Celldex Therapeutics share price volatility
Over the last 12 months, Celldex Therapeutics's shares have ranged in value from as little as $15.37 up to $57.2. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Celldex Therapeutics's is 2.7248. This would suggest that Celldex Therapeutics's shares are significantly more volatile than the average for this exchange and represent a higher risk.
Celldex Therapeutics overview
Celldex Therapeutics, Inc. , a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-0159, a Phase I monoclonal antibody that binds the receptor tyrosine kinase KIT and inhibits its activity; CDX-1140, a human agonist monoclonal antibody targeted to CD40, a key activator of immune response, which is found on dendritic cells, macrophages, and B cells, as well as is expressed on various cancer cells; and CDX-527, a bispecific antibody, which uses the company's proprietary active anti-PD-L1 and CD27 human antibodies to couple CD27 costimulation with blockade of the PD-L1/PD-1 pathway to help prime and activate anti-tumor T cell responses through CD27 costimulation. Celldex Therapeutics, Inc. has research collaboration and license agreements with University of Southampton to develop human antibodies towards CD27; Amgen Inc. with exclusive rights to CDX-301 and CD40 ligand; and Yale University.
Stocks similar to Celldex Therapeutics
Celldex Therapeutics in the news
Microsoft's $68.7 billion deal for Activision once again shows big tech's dominance over legacy media
Supreme Court vaccine mandate ruling won't bar companies from demanding Covid shots for workers — Biden vows to advocate for that
Two of Sen. Kyrsten Sinema's former aides have lobbied for corporate giants looking to influence Joe Biden's agenda
Frequently asked questions
More guides on Finder
How to buy Aritzia stock in Canada
Steps to owning and managing Aritzia (ATZ) stock, with 24-hour and historical pricing before you buy.
CI Direct Trading review
Get low fees and access many different types of accounts, platforms and investments with this reputable online broker.
Kusama (KSM) price prediction
Read our expert analysis on Kusama and how the token will perform in the future.
How to buy The Sandbox (SAND) in Canada
This guide provides step-by-step instructions on how to buy The Sandbox, lists some exchanges where you can get it and provides daily price data on SAND.
COVID testing stocks
We’ve rounded up stats on some of the most popular COVID testing stocks, along with information on how they compare and how to invest.
Shiba Inu (SHIB) price, history and performance
This guide explores the different ways of buying Shiba Inu on a cryptocurrency exchange as well as where you should store your cryptocurrency.
Baby Doge Coin (BABYDOGE) price, chart, coin profile and news
This guide provides step-by-step instructions on how to buy Baby Doge Coin, lists some exchanges where you can get it and provides daily price data on BABYDOGE.
Pendle (PENDLE) price, chart, coin profile and news
This guide provides step-by-step instructions on how to buy Pendle, lists some exchanges where you can get it and provides daily price data on PENDLE.
Hempcoin (THC) price, chart, coin profile and news
This guide provides step-by-step instructions on how to buy Hempcoin, lists some exchanges where you can get it and provides daily price data on THC.
The ChampCoin (TCC) price, chart, coin profile and news
This guide provides step-by-step instructions on how to buy The ChampCoin, lists some exchanges where you can get it and provides daily price data on TCC.